According to Regeneron Pharmaceuticals's latest financial reports the company's current EPS (TTM) is 34,63ย โฌ. In 2022 the company made an earnings per share (EPS) of 37,56ย โฌ a decrease over its 2021 EPS that were of 70,87ย โฌ.